Aktiesnakken — Marts 2010
-
genmab ender ikke på den korte bane som value
-
30 dage til salgstal
-
så ved vi om der er håb eller ej
-
hvorfor ikke ekstra ekstrapolere. Den ka altid gå i nul
-
salget skal jo ikke nødvendigvis doble engang i kvartalet
-
ja TDAE og det er ikke famlende på den fede måde (i.e. in a room full of tits)
-
for hvert kvartal der går med salgstal bliver casen valideret.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind